Iradimed Corporation

IRadimed Corporation (NASDAQ: IRMD) develops, manufactures, and markets innovative MRI compatible medical devices. We are the only known provider of non-magnetic intravenous (IV) infusion pump systems and non-magnetic patient vital signs monitors specifically designed for use during magnetic resonance imaging (MRI) procedures. IRadimed was founded in 2005 and became public in 2014 and currently holds leading market positions across the globe. This growth minded company is headquartered in Winter Springs, Florida.

IRadimed is a leader in MRI patient care with vast experience in MRI innovation. Roger Susi, our president and CEO, is the founder of Invivo Research where he pioneered the world’s first and best selling MRI patient vital signs monitoring brand, as well as founding IRadimed Corporation, the producer of the world’s first and best selling non-magnetic MRI infusion pumps and patient monitors.

The leadership team at IRadimed has a deep history in developing and advancing MRI patient care and is proud to introduce the world’s first and only portable, MRI multi-parameter vital signs monitor that maintains the continuum of care throughout the patient’s entire MRI care cycle.

Iradimed Corporation presents FMD Smart MRI, ferrous metal detector. The only FMD with TruSense threat qualification that significantly reduces alarm fatigue which may not be readily apparent to you until a catastrophic event occurs.

Company’s Keywords:

nonmagnetic mri patient vital sign monitors & nonmagnetic mri iv infusion pumps